Michael Goldstein's Insider Trades & SAST Disclosures
Michael Goldstein's most recent trade in Tucows, Inc. - Ordinary Shares - Class A was a trade of 2,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael Goldstein.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 2,500 | 2,500 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Michael H. Goldstein | President, Ophthalmology & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 190,000 | 190,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Michael H. Goldstein | President, Ophthalmology & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2022 | 63,333 | 313,335 (0%) | 0% | 0 | Common Stock | |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2021 | 2,500 | 0 | - | - | Stock Option (Right to Buy) | |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.41 per share. | 02 Dec 2021 | 2,500 | 5,282 (0%) | 0% | 19.4 | 48,525 | Common Stock |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.93 per share. | 24 Jun 2021 | 1,600 | 2,782 (0%) | 0% | 15.9 | 25,488 | Common Stock |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jun 2021 | 1,600 | 0 | - | - | Stock Option (Right to Buy) | |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | Chief Revenue Officer - Ting | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 3,000 | 3,000 | - | - | Stock Option (Right to Buy) | |
| Ocular Therapeutix Inc | Michael H. Goldstein | President, Ophthalmology & CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Teladoc Health Inc | Michael Goldstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jun 2020 | 7,689 | 0 | - | - | Stock Option (right to buy) | |
| Teladoc Health Inc | Michael Goldstein | Director | Sale of securities on an exchange or to another person at price $ 180.00 per share. | 11 Jun 2020 | 7,689 | 0 (0%) | 0% | 180 | 1,384,020 | Common Stock |
| Teladoc Health Inc | Michael Goldstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.50 per share. | 11 Jun 2020 | 7,689 | 7,689 (0%) | 0% | 30.5 | 234,515 | Common Stock |
| Teladoc Health Inc | Michael Goldstein | Director | Sale of securities on an exchange or to another person at price $ 163.00 per share. | 04 Jun 2020 | 8,000 | 0 (0%) | 0% | 163 | 1,304,000 | Common Stock |
| Teladoc Health Inc | Michael Goldstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2020 | 8,000 | 0 | - | - | Stock Option (right to buy) | |
| Teladoc Health Inc | Michael Goldstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.64 per share. | 04 Jun 2020 | 8,000 | 8,000 (0%) | 0% | 16.6 | 133,120 | Common Stock |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | VP Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 2,250 | 2,250 | - | - | Stock Option (Right to Buy) | |
| Teladoc Health Inc | Michael Goldstein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 1,049 | 1,049 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Michael Goldstein | Director | Sale of securities on an exchange or to another person at price $ 169.13 per share. | 16 Apr 2020 | 14,805 | 0 (0%) | 0% | 169.1 | 2,503,970 | Common Stock |
| Teladoc Health Inc | Michael Goldstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.71 per share. | 16 Apr 2020 | 13,105 | 14,023 (0%) | 0% | 8.7 | 114,145 | Common Stock |
| Teladoc Health Inc | Michael Goldstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2020 | 13,105 | 0 | - | - | Stock Option (right to buy) | |
| Teladoc Health Inc | Michael Goldstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.64 per share. | 16 Apr 2020 | 1,700 | 15,723 (0%) | 0% | 16.6 | 28,288 | Common Stock |
| Teladoc Health Inc | Michael Goldstein | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Apr 2020 | 1,700 | 8,000 | - | - | Stock Option (right to buy) | |
| Teladoc Health Inc | Michael Goldstein | Director | Sale of securities on an exchange or to another person at price $ 165.93 per share. | 16 Apr 2020 | 918 | 14,805 (0%) | 0% | 165.9 | 152,324 | Common Stock |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | VP Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2020 | 782 | 0 | - | - | Stock Option (Right to Buy) | |
| Tucows, Inc. - Ordinary Sh... | Michael Goldstein | VP Marketing | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.56 per share. | 13 Apr 2020 | 782 | 1,182 (0%) | 0% | 8.6 | 6,694 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges